Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.
Hematopoietic tissues are the targets of numerous xenobiotics. Clinical hematotoxicity is either a decrease or an increase in peripheral blood cell counts in one or more cell lineages--a cytopenia or a cytosis, respectively--that carries a risk of an adverse clinical event. The purpose of in vitro h...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
1998
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533375/ |